Market Research Logo

Global Transcatheter Mitral Valve Repair & Replacement (TMVR) Market: Industry Analysis & Outlook (2018-2022)

Global Transcatheter Mitral Valve Repair & Replacement (TMVR) Market: Industry Analysis & Outlook (2018-2022)

A human heart has four valves: Mitral valve, Tricuspid valve, Aortic valve and Pulmonary valve. Mitral valve is located on the left side of the heart and has two flaps which create a passage for oxygenated blood to travel from the left atrium to left ventricle. Mitral valve is attached by chordae tendinae to the papillary muscles which prevent the leaflets from prolapsing during ventricular contraction.

When the mitral valve does not close properly, then this condition is called Mitral Regurgitation. Mitral Regurgitation (MR) is a valve disorder where blood leaks backward through the mitral valve with heart contractions and reduces the amount of blood pumped through the body, which over time can lead to heart dysfunction and heart failure. Mitral Regurgitation can be of two types: Functional Mitral Regurgitation (FMR) and Degenerative Mitral Regurgitation (DMR).

Europe is a major contributor to the global TMVR market supported by increased ageing and obese population, better accessibility and favorable reimbursement policies for TMVR. The U.S. is also expecting a high growth rate in TMVR market due to rising development of TMVR devices and incidences of heart diseases.

The global TMVR market is expected to grow in future due to increasing ageing population, obese population, rising healthcare expenditure and economic growth. Key trends of this market include leading causes of death in the U.S., factors affecting the development of TMVR devices, prevalence of mitral regurgitation by age group in the U.S. and growing adoption of minimally invasive therapies. However, there are some factors which can hinder the market growth including associated high risks and tough regulatory problems.

The report “Global TMVR Market: Industry Analysis & Outlook (2018-2022)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S., and Europe region along with the global market. The report profiles the key players of the market including Medtronic plc, Abbott Laboratories, Edwards and LivaNova Plc.


1. Overview
1.1 Mitral Regurgitation
Table 1: Types of Mitral Regurgitation
1.2 Traditional Surgical Method
1.3 TMVR
1.4 Benefits and Risk Associated with TMVR
2. Global TMVR Market Analysis
2.1 TMVR Market Value Forecast
Table 2: Global TMVR Market Value Forecast (2017-2022)
2.2 TMVR Market by Region
Table 3: Global TMVR Market by Region (2017)
2.3 TMVR Market Volume Forecast
Table 4: Global TMVR Market Volume Forecast (2017-2022)
2.4 MR Patient Population
Table 5: Global MR Patient Population (2013-2017)
2.5 MR Patient Population Forecast
Table 6: Global MR Patient Population Forecast (2018-2022)
2.6 Surgically Treated MR Patient Population Forecast
Table 7: Global Surgically Treated MR Patient Population Forecast (2017-2022)
2.7 High Risk MR Patient Population Forecast
Table 8: Global High Risk MR Patient Population Forecast (2017-2022)
3. Regional Market Analysis
3.1 The U.S.
3.1.1 The U.S. TMVR Market Value Forecast
Table 9: The U.S. TMVR Market Value Forecast (2017-2022)
3.1.2 The U.S. TMVR Market Value Forecast by Type
Table 10: The U.S. TMVR Market Value Forecast by Type (2017-2022)
3.1.3 The U.S. TMVR Market Volume Forecast
Table 11: The U.S. TMVR Market Volume Forecast (2017-2022)
3.1.4 The U.S. TMVR Market Volume Forecast by Type
Table 12: The U.S. TMVR Market Volume Forecast by Type (2017-2022)
3.1.5 The U.S. Mitral Regurgitation Patient Population
Table 13: The U.S. Mitral Regurgitation Patient Population (2013-2017)
3.1.6 The U.S. Mitral Regurgitation Patient Population Forecast
Table 14: The U.S. Mitral Regurgitation Patient Population Forecast (2018-2022)
3.1.7 The U.S. Surgically Treated MR Patient Population Forecast
Table 15: The U.S. Surgically Treated MR Patient Population Forecast (2017-2022)
3.1.8 The U.S. High Risk MR Patient Population Forecast
Table 16: The U.S. High Risk MR Patient Population Forecast (2017-2022)
3.2 Europe
3.2.1 Europe TMVR Market Value Forecast
Table 17: Europe TMVR Market Value Forecast (2017-2022)
3.2.2 Europe TMVR Market Value Forecast by Type
Table 18: Europe TMVR Market Value Forecast by Type (2017-2022)
3.2.3 Europe TMVR Market Volume Forecast
Table 19: Europe TMVR Market Volume Forecast (2017-2022)
3.2.4 Europe TMVR Market Volume Forecast by Type
Table 20: Europe TMVR Market Volume Forecast by Type (2017-2022)
3.2.5 Europe MR Patient Population
Table 21: Europe MR Patient Population (2013-2017)
3.2.6 Europe MR Patient Population Forecast
Table 22: Europe MR Patient Population Forecast (2018-2022)
3.2.7 Europe Surgically Treated MR Patient Population Forecast
Table 23: Europe Surgically Treated MR Patient Population Forecast (2017-2022)
3.2.8 Europe High Risk MR Patient Population Forecast
Table 24: Europe High Risk MR Patient Population Forecast (2017-2022)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Growing Ageing Population
Table 25: Global Ageing Population (2013-2017)
4.1.2 Escalating Healthcare Spending
Table 26: Global Healthcare Spending Per Capita (2013-2017)
4.1.3 Rising GDP Per Capita
Table 27: Global GDP Per Capita (2013-2017)
4.1.4 Increase in Obese Population
Table 28: Global Obese Population (2013-2017)
4.2 Key Trends & Developments
4.2.1 Leading Causes of Death in The U.S
Table 29: Most Common Causes of Death in the U.S. (2017)
4.2.2 Factors Affecting the Development of TMVR Devices
Table 30: Challenging Factors for TMVR Devices Development (2017)
4.2.3 Prevalence of MR by Age Group in the U.S
Table 31: The U.S. MR Prevalence by Age Group (2017)
4.2.4 Growing Adoption of Minimally Invasive Therapies
4.3 Challenges
4.3.1 Associated High Risk
4.3.2 Tough Regulatory Problems
5. Competition
5.1 Global Market
5.1.1 Key Competitors and Devices in the Global TMVR Market
Table 32: Key Competitors and Their Devices (2017)
5.1.2 Revenue Comparison of Key Players
Table 33: Revenue Comparison of Key Players (2017)
5.1.3 Market Cap Comparison of Key Players
Table 34: Market Cap Comparison of Key Players
6. Company Profiles
6.1 Medtronic Plc.
6.1.1 Business Overview
Table 35: Medtronic Plc. Revenue by Segments (2017)
6.1.2 Financial Overview
Table 36: Medtronic Plc. Net Sales and Net Income (2013-2017)
6.1.3 Business Strategies
6.2 Abbott Laboratories
6.2.1 Business Overview
Table 37: Abbott Laboratories Revenue by Segments (2017)
6.2.2 Financial Overview
Table 38: Abbott Laboratories Net Sales and Net Earnings (2013-2017)
6.2.3 Business Strategies
Table 39: Abbott Laboratories R&D Expenditure (2015-2017)
6.3 Edwards Lifesciences
6.3.1 Business Overview
Table 40: Edwards Lifesciences Corporation Revenue by Segments (2017)
6.3.2 Financial Overview
Table 41: Edwards Lifesciences Net Sales and Net Income (2013-2017)
6.3.3 Business Strategies
Table 42: Edwards Lifesciences R&D Expenditure (2015-2017)
6.4 LivaNova Plc
6.4.1 Business Overview
Table 43: LivaNova Plc Sales by Segment (2017)
6.4.2 Financial Overview
Table 44: LivaNova Plc. Net Sales and Net Income (2013-2017)
6.4.3 Business Strategies
Table 45: LivaNova Plc. R&D Expenditure (2015-2017)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report